130 related articles for article (PubMed ID: 38477638)
1. Evaluation of pancreatic cancer specimens for comprehensive genomic profiling.
Washimi K; Hiroshima Y; Sato S; Ueno M; Kobayashi S; Yamamoto N; Hasegawa C; Yoshioka E; Ono K; Okubo Y; Yokose T; Miyagi Y
Pathol Int; 2024 May; 74(5):252-261. PubMed ID: 38477638
[TBL] [Abstract][Full Text] [Related]
2. Genomic profile concordance between pancreatic cyst fluid and neoplastic tissue.
Laquière AE; Lagarde A; Napoléon B; Bourdariat R; Atkinson A; Donatelli G; Pol B; Lecomte L; Curel L; Urena-Campos R; Helbert T; Valantin V; Mithieux F; Buono JP; Grandval P; Olschwang S
World J Gastroenterol; 2019 Sep; 25(36):5530-5542. PubMed ID: 31576098
[TBL] [Abstract][Full Text] [Related]
3. Genomic testing for pancreatic cancer in clinical practice as real-world evidence.
Hayashi H; Tanishima S; Fujii K; Mori R; Okamura Y; Yanagita E; Matsuoka R; Amano T; Kinoshita I; Komatsu Y; Dosaka-Akita H; Nishihara H
Pancreatology; 2018 Sep; 18(6):647-654. PubMed ID: 30055942
[TBL] [Abstract][Full Text] [Related]
4. A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases.
Nishiwada S; Sho M; Banwait JK; Yamamura K; Akahori T; Nakamura K; Baba H; Goel A
Gastroenterology; 2020 Aug; 159(2):562-574. PubMed ID: 32376411
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic cancer subtypes: a roadmap for precision medicine.
Torres C; Grippo PJ
Ann Med; 2018 Jun; 50(4):277-287. PubMed ID: 29537309
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic acinar cell carcinoma: A review on molecular profiling of patient tumors.
Al-Hader A; Al-Rohil RN; Han H; Von Hoff D
World J Gastroenterol; 2017 Dec; 23(45):7945-7951. PubMed ID: 29259370
[TBL] [Abstract][Full Text] [Related]
7. Minimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomes.
San Lucas FA; Allenson K; Bernard V; Castillo J; Kim DU; Ellis K; Ehli EA; Davies GE; Petersen JL; Li D; Wolff R; Katz M; Varadhachary G; Wistuba I; Maitra A; Alvarez H
Ann Oncol; 2016 Apr; 27(4):635-41. PubMed ID: 26681674
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic Profiling.
Pal SK; Ali SM; Yakirevich E; Geynisman DM; Karam JA; Elvin JA; Frampton GM; Huang X; Lin DI; Rosenzweig M; Lipson D; Stephens PJ; Ross JS; Miller VA; Agarwal N; Shuch B; Choueiri TK; Chung JH
Eur Urol; 2018 Jan; 73(1):71-78. PubMed ID: 28592388
[TBL] [Abstract][Full Text] [Related]
9. Factors Impacting Clinically Relevant RNA Fusion Assays Using Next-Generation Sequencing.
Ramani NS; Patel KP; Routbort MJ; Alvarez H; Broaddus R; Chen H; Rashid A; Lazar A; Lucas FAS; Yao H; Manekia J; Dang H; Barkoh BA; Medeiros LJ; Luthra R; Roy-Chowdhuri S
Arch Pathol Lab Med; 2021 Nov; 145(11):1405-1412. PubMed ID: 33493304
[TBL] [Abstract][Full Text] [Related]
10. Genomic profiling amplifies the utility of endoscopic ultrasound-guided fine needle biopsy by identifying clinically applicable druggable mutations in pancreatic cancer.
Ohyama H; Mikata R; Hirotsu Y; Amemiya K; Miura Y; Hirose S; Oyama T; Takano A; Iimuro Y; Kojima Y; Mochizuki H; Ikeda J; Kato N; Omata M
Ann Diagn Pathol; 2022 Oct; 60():152016. PubMed ID: 35905537
[TBL] [Abstract][Full Text] [Related]
11. Challenges of the current precision medicine approach for pancreatic cancer: A single institution experience between 2013 and 2017.
Ding D; Javed AA; Cunningham D; Teinor J; Wright M; Javed ZN; Wilt C; Parish L; Hodgin M; Ryan A; Judkins C; McIntyre K; Klein R; Azad N; Lee V; Donehower R; De Jesus-Acosta A; Murphy A; Le DT; Shin EJ; Lennon AM; Khashab M; Singh V; Klein AP; Roberts NJ; Hacker-Prietz A; Manos L; Walsh C; Groshek L; Brown C; Yuan C; Blair AB; Groot V; Gemenetzis G; Yu J; Weiss MJ; Burkhart RA; Burns WR; He J; Cameron JL; Narang A; Zaheer A; Fishman EK; Thompson ED; Anders R; Hruban RH; Jaffee E; Wolfgang CL; Zheng L; Laheru DA
Cancer Lett; 2021 Jan; 497():221-228. PubMed ID: 33127389
[TBL] [Abstract][Full Text] [Related]
12. Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants.
Dimitrakopoulos C; Vrugt B; Flury R; Schraml P; Knippschild U; Wild P; Hoerstrup S; Henne-Bruns D; Wuerl P; Graf R; Breitenstein S; Bond G; Beerenwinkel N; Grochola LF
JAMA Surg; 2019 Jun; 154(6):e190484. PubMed ID: 30942874
[TBL] [Abstract][Full Text] [Related]
13. Clinical Application of Genomic Profiling With Circulating Tumor DNA for Management of Advanced Non-Small-cell Lung Cancer in Asia.
Loong HH; Raymond VM; Shiotsu Y; Chua DTT; Teo PML; Yung T; Skrzypczak S; Lanman RB; Mok TSK
Clin Lung Cancer; 2018 Sep; 19(5):e601-e608. PubMed ID: 29807856
[TBL] [Abstract][Full Text] [Related]
14. Can pancreatic neuroendocrine tumour biopsy accurately determine pathological characteristics?
Rebours V; Cordova J; Couvelard A; Fabre M; Palazzo L; Vullierme MP; Hentic O; Sauvanet A; Aubert A; Bedossa P; Ruszniewski P
Dig Liver Dis; 2015 Nov; 47(11):973-7. PubMed ID: 26169284
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma.
Schultz NA; Werner J; Willenbrock H; Roslind A; Giese N; Horn T; Wøjdemann M; Johansen JS
Mod Pathol; 2012 Dec; 25(12):1609-22. PubMed ID: 22878649
[TBL] [Abstract][Full Text] [Related]
16. Using circulating cell-free DNA to monitor personalized cancer therapy.
Oellerich M; Schütz E; Beck J; Kanzow P; Plowman PN; Weiss GJ; Walson PD
Crit Rev Clin Lab Sci; 2017 May; 54(3):205-218. PubMed ID: 28393575
[TBL] [Abstract][Full Text] [Related]
17. Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms.
Young G; Wang K; He J; Otto G; Hawryluk M; Zwirco Z; Brennan T; Nahas M; Donahue A; Yelensky R; Lipson D; Sheehan CE; Boguniewicz AB; Stephens PJ; Miller VA; Ross JS
Cancer Cytopathol; 2013 Dec; 121(12):688-94. PubMed ID: 23893923
[TBL] [Abstract][Full Text] [Related]
18. [Three Resected Cases of Metachronous Pancreatic Cancer Successfully Treated with Repeated Pancreatectomy].
Noguchi K; Tomimaru Y; Eguchi H; Ogawa H; Yamada D; Tomokuni A; Noda T; Asaoka T; Wada H; Kawamoto K; Goto K; Marubashi S; Nagano H; Mori M; Doki Y
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2346-8. PubMed ID: 26805359
[TBL] [Abstract][Full Text] [Related]
19. Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative.
Pishvaian MJ; Bender RJ; Halverson D; Rahib L; Hendifar AE; Mikhail S; Chung V; Picozzi VJ; Sohal D; Blais EM; Mason K; Lyons EE; Matrisian LM; Brody JR; Madhavan S; Petricoin EF
Clin Cancer Res; 2018 Oct; 24(20):5018-5027. PubMed ID: 29954777
[No Abstract] [Full Text] [Related]
20. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.
Groisberg R; Hong DS; Holla V; Janku F; Piha-Paul S; Ravi V; Benjamin R; Kumar Patel S; Somaiah N; Conley A; Ali SM; Schrock AB; Ross JS; Stephens PJ; Miller VA; Sen S; Herzog C; Meric-Bernstam F; Subbiah V
Oncotarget; 2017 Jun; 8(24):39254-39267. PubMed ID: 28424409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
